Dae Gon Ha
Stock Analyst at Stifel
(2.60)
# 2,317
Out of 5,090 analysts
46
Total ratings
36.84%
Success rate
7.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dae Gon Ha
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Reinstates: Buy | $89 | $68.48 | +29.96% | 4 | Aug 11, 2025 | |
| ABEO Abeona Therapeutics | Maintains: Buy | $21 → $20 | $4.88 | +310.26% | 2 | May 16, 2025 | |
| EDIT Editas Medicine | Downgrades: Hold | $11 → $3 | $2.42 | +23.97% | 4 | Dec 13, 2024 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $59 → $74 | $51.37 | +44.05% | 2 | Oct 1, 2024 | |
| FULC Fulcrum Therapeutics | Downgrades: Hold | $22 → $3 | $8.90 | -66.29% | 4 | Sep 12, 2024 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $80 → $64 | $9.61 | +565.97% | 2 | Sep 11, 2024 | |
| KRYS Krystal Biotech | Maintains: Buy | $204 → $220 | $234.13 | -6.04% | 4 | Sep 11, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $124 → $127 | $36.38 | +249.09% | 2 | May 31, 2024 | |
| RCKT Rocket Pharmaceuticals | Reiterates: Buy | $48 | $3.32 | +1,345.78% | 4 | Sep 13, 2023 | |
| PRME Prime Medicine | Initiates: Buy | $18 | $3.74 | +381.28% | 1 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $0.85 | +721.21% | 1 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $25 | $104.60 | -76.10% | 4 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 → $16 | $9.90 | +61.62% | 3 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $285 | $20.46 | +1,292.96% | 1 | Sep 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $2.09 | +856.94% | 1 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.24 | - | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $23.63 | - | 1 | Jun 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $7.59 | - | 1 | Jun 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.06 | +1,032.08% | 1 | Jun 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $600 → $490 | $13.90 | +3,425.18% | 2 | Oct 23, 2017 |
Mirum Pharmaceuticals
Aug 11, 2025
Reinstates: Buy
Price Target: $89
Current: $68.48
Upside: +29.96%
Abeona Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $21 → $20
Current: $4.88
Upside: +310.26%
Editas Medicine
Dec 13, 2024
Downgrades: Hold
Price Target: $11 → $3
Current: $2.42
Upside: +23.97%
Soleno Therapeutics
Oct 1, 2024
Maintains: Buy
Price Target: $59 → $74
Current: $51.37
Upside: +44.05%
Fulcrum Therapeutics
Sep 12, 2024
Downgrades: Hold
Price Target: $22 → $3
Current: $8.90
Upside: -66.29%
Intellia Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $80 → $64
Current: $9.61
Upside: +565.97%
Krystal Biotech
Sep 11, 2024
Maintains: Buy
Price Target: $204 → $220
Current: $234.13
Upside: -6.04%
Ultragenyx Pharmaceutical
May 31, 2024
Maintains: Buy
Price Target: $124 → $127
Current: $36.38
Upside: +249.09%
Rocket Pharmaceuticals
Sep 13, 2023
Reiterates: Buy
Price Target: $48
Current: $3.32
Upside: +1,345.78%
Prime Medicine
Apr 18, 2023
Initiates: Buy
Price Target: $18
Current: $3.74
Upside: +381.28%
Mar 24, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $0.85
Upside: +721.21%
Jun 17, 2022
Maintains: Buy
Price Target: $23 → $25
Current: $104.60
Upside: -76.10%
Nov 15, 2021
Upgrades: Buy
Price Target: $12 → $16
Current: $9.90
Upside: +61.62%
Sep 7, 2021
Initiates: Buy
Price Target: $285
Current: $20.46
Upside: +1,292.96%
May 3, 2021
Initiates: Buy
Price Target: $20
Current: $2.09
Upside: +856.94%
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $10.24
Upside: -
Jun 17, 2020
Initiates: Neutral
Price Target: n/a
Current: $23.63
Upside: -
Jun 17, 2020
Initiates: Neutral
Price Target: n/a
Current: $7.59
Upside: -
Jun 17, 2020
Initiates: Buy
Price Target: $12
Current: $1.06
Upside: +1,032.08%
Oct 23, 2017
Maintains: Outperform
Price Target: $600 → $490
Current: $13.90
Upside: +3,425.18%